Palomar Medical Technologies (PMTI) and Its Rivals Financial Survey
Palomar Medical Technologies (NASDAQ: PMTI) is one of 80 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its rivals? We will compare Palomar Medical Technologies to similar companies based on the strength of its valuation, dividends, risk, profitability, earnings, analyst recommendations and institutional ownership.
This is a breakdown of recent ratings and target prices for Palomar Medical Technologies and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Palomar Medical Technologies||0||0||0||0||N/A|
|Palomar Medical Technologies Competitors||213||1239||2641||93||2.62|
Institutional & Insider Ownership
65.7% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Palomar Medical Technologies and its rivals gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Palomar Medical Technologies||N/A||N/A||-49.67|
|Palomar Medical Technologies Competitors||$975.11 million||$120.37 million||225.28|
Palomar Medical Technologies’ rivals have higher revenue and earnings than Palomar Medical Technologies. Palomar Medical Technologies is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This table compares Palomar Medical Technologies and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Palomar Medical Technologies||N/A||N/A||N/A|
|Palomar Medical Technologies Competitors||-427.68%||-43.56%||-12.63%|
Risk & Volatility
Palomar Medical Technologies has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Palomar Medical Technologies’ rivals have a beta of 0.92, indicating that their average share price is 8% less volatile than the S&P 500.
Palomar Medical Technologies Company Profile
Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.
Receive News & Ratings for Palomar Medical Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar Medical Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.